吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jan 17 2023

Full Issue

CDC Reviewing Safety Of Pfizer Bivalent Booster For Seniors; Still Recommends Shot

The CDC said Friday that its Vaccine Safety Datalink surveillance system detected a preliminary safety signal for stroke in people ages 65 and older, which led to the investigation. None of the agency's other monitoring programs have identified any concerns, which leads the CDC to say that it's "very unlikely." No other covid vaccines have been flagged.

The Centers for Disease Control and Prevention on Friday said it is 鈥渧ery unlikely鈥 the Pfizer omicron booster carries a risk of stroke for seniors after it launched an investigation into a preliminary safety concern detected by one of its monitoring systems. (Kimball, 1/13)

The Centers for Disease Control and Prevention (CDC) says that a preliminary COVID-19 vaccine "safety signal" has been identified and is investigating whether the Bivalent Pfizer-BioNTech vaccine creates an increased risk of ischemic stroke in people 65 and older. In the Friday statement, the CDC said that the preliminary signal hasn't been identified with the Bivalent Moderna COVID-19 vaccine. (Sabes, 1/13)

The potential risk with Pfizer鈥檚 vaccine was not seen in other safety databases, nor was it seen with Moderna Inc.鈥檚 Covid vaccine, the officials said in a statement on the Food and Drug Administration鈥檚 website. The early finding still needs more investigation, and recommendations for the vaccine have not been changed, the statement said.聽(Langreth and Rutherford, 1/13)

In related news about vaccines and covid treatments 鈥

Pfizer鈥檚 new COVID-19 booster ad starring Martha Stewart is both rather odd and strangely聽compelling to watch in a definitive departure from its previous conservative vaccine commercials.聽The 30-second聽spot,聽鈥淯nwelcome Guest,鈥 features Stewart in her beautifully perfect kitchen calmly sharpening a massive Samurai sword. (Coey, 1/13)

The antidepressant fluvoxamine doesn't shorten the duration of COVID-19 symptoms in mildly to moderately ill adults, according to a randomized clinical trial (RCT) published yesterday in JAMA. (Van Beusekom, 1/13)

A Mayo Clinic鈥搇ed meta-analysis suggests that transfusion of COVID-19 convalescent plasma improves survival in hospitalized, infected patients who have impaired immune systems. The antibody-rich plasma, donated by COVID-19 survivors, may help prevent the reinfections to which these high-risk patients are susceptible, the researchers said. The study was published yesterday in JAMA Network Open. (Van Beusekom, 1/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
  • Friday, July 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF